RXRX Earnings — Recursion Pharmaceuticals, Inc. Class A Common Stock Post-ER Performance | BigEarnings
RXRX — Recursion Pharmaceuticals, Inc. Class A Common Stock
XNAS · Healthcare · Biotechnology
Price$2.94
Market Cap$1.5B
P/E—
52W Range$2.77 – $7.18
Next Earnings2026-08-04
About Recursion Pharmaceuticals, Inc. Class A Common Stock
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
